| Business Summary | | Diametrics
Medical,
Inc.
develops,
manufactures
and
commercializes
blood
and
tissue
analysis
systems
that
provide
immediate
or
continuous
diagnostic
results
at
the
point
of
patient
care.
The
Company
has
two
primary
product
platforms.
The
first
platform
includes
intermittent
blood
testing
products
based
primarily
on
electrochemical
technology
(the
IRMA
SL
Blood
Analysis
System),
and
the
second
platform
includes
continuous
monitoring
products
based
upon
fiber
optic
technology
(the
Trendcare
Continuous
Blood
Gas
Monitoring
Systems
and
the
Neurotrend
Cerebral
Tissue
Monitoring
System). | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Diametrics
Medical,
Inc.
develops,
manufactures
and
markets
a
proprietary
blood
chemistry
testing
system
that
provides
diagnostic
results
at
the
patient
point
of
care.
For
the
six
months
ended
6/30/01,
revenues
increased
1%
to
$11.8
million.
Net
loss
increased
6%
to
$2.2
million.
Results
reflect
increased
IRMA
product
line
sales
due
to
increased
cartridge
and
instrument
unit
sales,
offset
by
lower
gross
margins
and
higher
other
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| David Giddings, 57 Chairman,
Pres, CEO | $536K | Roy Johnson, 48 Exec.
VP; Pres and Managing Director of Diametrics Medical, Ltd.; Director | 273K | Laurence Betterley, 47 Sr.
VP, CFO | 255K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|